Debbie Watson

UOW Scholars Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 10

Top Venues

Clinical & translational immunology

Purinergic signalling

Immunology and cell biology

Methods in molecular biology (Clifton, N.J.)

University of Wollongong

University of Sydney (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Wollongong Jan 27 2019

Australia

Research Fellow :: School of Chemistry and Molecular Bioscience

Australasian Registry of Rare and Genetic Kidney Disease (ARRK)

Australia

Project Officer :: Nephrology

University of Wollongong

Australia

Research Fellow :: School of Biological Sciences, Faculty of Science, Medicine and Health

University of Wollongong Apr 01 2009 - Sep 30 2013

Australia

NHMRC Research Fellow :: School of Biological Sciences, Faculty of Science, Medicine and Health

Education History

University of Sydney

Australia

PHD :: Faculty of Medicine

Macquarie University

Australia

BSC :: School of Biological Sciences

Publications

Chloe Sligar, Ellie Reilly, Peter Cuthbertson, Kara Lea Vine, Katrina M Bird, Amal Elhage, Stephen I Alexander, Ronald Sluyter, Debbie Watson
Graft-versus-leukaemia immunity is retained following treatment with post-transplant cyclophosphamide alone or combined with tocilizumab in humanised mice. Clinical & translational immunology 13 (3) (2024)
Chloe Sligar, Ellie Reilly, Peter Cuthbertson, Kara Lea Vine, Katrina M Bird, Amal Elhage, Stephen I Alexander, Ronald Sluyter, Debbie Watson
Graft-versus-leukaemia immunity is retained following treatment with post-transplant cyclophosphamide alone or combined with tocilizumab in humanised mice. Clinical & translational immunology 13 (3) (2024)
Amal Elhage, Chloe Sligar, Peter Cuthbertson, Debbie Watson, Ronald Sluyter
Insights into mechanisms of graft-versus-host disease through humanised mouse models. Bioscience reports 42 (9) (2022)
Debbie Watson, Sam R Adhikary, Peter Cuthbertson, Nicholas J Geraghty, Katrina M Bird, Amal Elhage, Chloe Sligar, Ronald Sluyter
Humanized Mouse Model to Study the P2X7 Receptor in Graft-Versus-Host Disease. Methods in molecular biology (Clifton, N.J.) 2510 (2022)
Amal Elhage, Ross J Turner, Peter Cuthbertson, Debbie Watson, Ronald Sluyter
Preparation of the Murine Anti-Human P2X7 Receptor Monoclonal Antibody (Clone L4). Methods in molecular biology (Clifton, N.J.) 2510 (2022)
Sam R Adhikary, Peter Cuthbertson, Leigh Nicholson, Katrina M Bird, Chloe Sligar, Min Hu, Philip J O'Connell, Ronald Sluyter, Stephen I Alexander, Debbie Watson
Post-transplant cyclophosphamide limits reactive donor T cells and delays the development of graft-versus-host disease in a humanized mouse model. Immunology 164 (2) (2021)
Ross J Turner, Nicholas J Geraghty, Jonathan G Williams, Diane Ly, Daniel Brungs, Martin G Carolan, Thomas V Guy, Debbie Watson, Jeremiah F de Leon, Ronald Sluyter
Comparison of peripheral blood mononuclear cell isolation techniques and the impact of cryopreservation on human lymphocytes expressing CD39 and CD73. Purinergic signalling 16 (3) (2020)
Diane Ly, Anjila Dongol, Peter Cuthbertson, Thomas V Guy, Nicholas J Geraghty, Reece Andrew Sophocleous, Lucia Sin, Bradley J Turner, Debbie Watson, Justin J Yerbury, Ronald Sluyter
The P2X7 receptor antagonist JNJ-47965567 administered thrice weekly from disease onset does not alter progression of amyotrophic lateral sclerosis in SOD1G93A mice. Purinergic signalling 16 (1) (2020)
Sam R Adhikary, Peter Cuthbertson, Ross J Turner, Ronald Sluyter, Debbie Watson
A single-nucleotide polymorphism in the human ENTPD1 gene encoding CD39 is associated with worsened graft-versus-host disease in a humanized mouse model. Immunology and cell biology 98 (5) (2020)
Nicholas J Geraghty, Debbie Watson, Ronald Sluyter
Pharmacological blockade of the CD39/CD73 pathway but not adenosine receptors augments disease in a humanized mouse model of graft-versus-host disease. Immunology and cell biology 97 (6) (2019)

Debbie Watson.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Debbie Watson